Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma, Adult”

562 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 562 results

Testing effectiveness (Phase 2)Study completedNCT01067469
What this trial is testing

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma
M.D. Anderson Cancer Center 83
Not applicableNot Yet RecruitingNCT06781372
What this trial is testing

Patient's Derived Organoids for Drug Screening in Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme (GBM)Glioblastoma Multiforme, Adult
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableStudy completedNCT04610229
What this trial is testing

Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.

Who this might be right for
Glioblastoma MultiformeGlioblastomaGlioblastoma, Adult
Azienda USL Reggio Emilia - IRCCS 12
Testing effectiveness (Phase 2)Study completedNCT02858895
What this trial is testing

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Who this might be right for
GlioblastomaGrade IV AstrocytomaGlioblastoma Multiforme+1 more
Medicenna Therapeutics, Inc. 47
Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Testing effectiveness (Phase 2)Looking for participantsNCT03213002
What this trial is testing

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more
Northwell Health 67
Early research (Phase 1)Ended earlyNCT01103375
What this trial is testing

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
Wake Forest University Health Sciences 5
Testing effectiveness (Phase 2)Study completedNCT00262730
What this trial is testing

Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 97
Early research (Phase 1)Looking for participantsNCT06186401
What this trial is testing

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Who this might be right for
EGFR Gene MutationGlioblastomaMGMT-Unmethylated Glioblastoma+1 more
Hideho Okada, MD, PhD 20
Very early researchStudy completedNCT05977738
What this trial is testing

Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin

Who this might be right for
Glioblastoma Multiforme, AdultRecurrent Glioblastoma
C.Dirven 12
Testing effectiveness (Phase 2)Study completedNCT00003417
What this trial is testing

Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 40
Testing effectiveness (Phase 2)Study completedNCT01310868
What this trial is testing

Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma

Who this might be right for
Glioblastoma
University College, London 59
Testing effectiveness (Phase 2)Study completedNCT00004017
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Peregrine Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Testing effectiveness (Phase 2)Study completedNCT00004200
What this trial is testing

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Next Page